Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection

Wirth S, Rosenthal P, Gonzalez-Peralta RP, et al. Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2017;66(4):1102-1110.

Publication Type:

Journal Article

Authors:

Wirth, Stefan; Rosenthal, Philip; Gonzalez-Peralta, Regino P.; et, al

Source:

Hepatology, Volume 66, Issue 4, p.1102-1110 (2017)

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/28543053

Export Citation:
RIS Format
Top